Citadel Advisors - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 87 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$88,000
-74.3%
80,112
-68.0%
0.00%
Q2 2020$343,000
-17.5%
250,062
-31.6%
0.00%
Q1 2020$416,000
-39.8%
365,446
+20.5%
0.00%
Q4 2019$691,000
+774.7%
303,384
+220.5%
0.00%
Q3 2019$79,000
-55.6%
94,667
-48.2%
0.00%
Q2 2019$178,000
-52.7%
182,898
-38.8%
0.00%
Q1 2019$376,000
-0.5%
298,858
+155.7%
0.00%
Q4 2018$378,000
+289.7%
116,882
+190.9%
0.00%
Q3 2018$97,000
-66.0%
40,180
-60.7%
0.00%
Q2 2018$285,000
-27.8%
102,325
+303.7%
0.00%
Q3 2016$395,00025,3450.00%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q1 2019.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders